Phase III, randomized, open-label, comparative safety and efficacy trial of IV iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anemia who are intolerant or unresponsive to oral iron therapy or in whom the hemoglobin measurement in Investigators’ opinion were sufficiently low as to require rapid repletion of iron stores to minimize the risk of receiving a blood transfusion.

Type of Cancer
Unknown

Site
Bethesda

Protocol Number
P-MONOFER-IDA-03

To Learn More Call
201-510-0910